Intra-arterial steroid-injection therapy for steroid-refractory acute graft-versus-host disease with the evaluation of angiography

被引：11

作者：

Nakai, K ^{[1
]}

Tajima, K ^{[1
]}

Tanigawa, N ^{[1
]}

Matsumoto, N ^{[1
]}

Zen, K ^{[1
]}

Nomura, S ^{[1
]}

Fujimoto, M ^{[1
]}

Kishimoto, Y ^{[1
]}

Amakawa, R ^{[1
]}

Sawada, S ^{[1
]}

Fukuhara, S ^{[1
]}

机构：

[1] Kansai Med Univ, Dept Internal Med 1, Moriguchi, Osaka 5708672, Japan

来源：

BONE MARROW TRANSPLANTATION | 2004年 / 33卷 / 12期

关键词：

intra-arterial steroid-injection therapy; steroidrefractory; acute graft-versus-host disease; angiography;

D O I：

10.1038/sj.bmt.1704523

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

We treated three patients with steroid-refractory acute graft-versus-host disease (aGVHD) with intra-arterial steroid-injection therapy (IAST). Two patients with gut aGVHD received IAST into both superior and inferior mesenteric arteries, while one patient with liver aGVHD received IAST into the proper hepatic artery. The volume of stools and the bilirubin level improved soon after IAST. Angiography of the superior and inferior mesenteric arteries was performed in the two patients with steroid-refractory gut aGVHD, and identical abnormal findings were obtained. IAST might be an earlier option for steroid-refractory aGVHD.

引用

页码：1231 / 1233

页数：3

共 11 条

[1] Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment [J].

Arai, S ;

Margolis, J ;

Zaburak, M ;

Anders, V ;

Vogelsang, GB .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2002, 8 (03) :155-160

[2] SELECTIVE INTRA-ARTERIAL STEROID INJECTION IN ULCERATIVE-COLITIS [J].

HIRAMATSU, K ;

ASAKURA, H ;

BABA, S .

ACTA RADIOLOGICA-DIAGNOSIS, 1976, 17 (03) :299-304

[3]

MARTIN PJ, 1991, BLOOD, V77, P1821

[4] Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients:: a cohort study [J].

Marty, FM ;

Lee, SJ ;

Fahey, MM ;

Alyea, EP ;

Soiffer, RJ ;

Antin, JH ;

Baden, LR .

BLOOD, 2003, 102 (08) :2768-2776

[5] Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease [J].

Przepiorka, D ;

Kernan, NA ;

Ippoliti, C ;

Papadopoulos, EB ;

Giralt, S ;

Khouri, I ;

Lu, JG ;

Gajewski, J ;

Durett, A ;

Cleary, K ;

Champlin, R ;

Andersson, BS ;

Light, S .

BLOOD, 2000, 95 (01) :83-89

[6]

Rogler G, 1999, EUR J CLIN INVEST, V29, P330

[7]

Sato T, 1997, AM J HEMATOL, V56, P277, DOI 10.1002/(SICI)1096-8652(199712)56:4<277::AID-AJH14>3.0.CO

[8]

2-6

[9]

Schottelius A, 2000, AM J GASTROENTEROL, V95, P1994

[10] Intra-arterial catheter directed therapy for severe graft-versus-host disease [J].

Shapira, MY ;

Bloom, AI ;

Or, R ;

Sasson, T ;

Nagler, A ;

Resnick, IB ;

Aker, M ;

Zilberman, I ;

Slavin, S ;

Verstanding, A .

BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (03) :760-764

← 1 2 →